User:Mr. Ibrahem/Isosorbide mononitrate

From Wikipedia, the free encyclopedia
Mr. Ibrahem/Isosorbide mononitrate
Clinical data
Trade namesMonoket, Imdur, others
AHFS/Drugs.comMonograph
MedlinePlusa682348
License data
Pregnancy
category
Routes of
administration		By mouth
Legal status
Legal status
Pharmacokinetic data
Bioavailability>95%
Protein binding<5%
MetabolismHepatic
Elimination half-life5 hours
ExcretionKidney (93%)
Identifiers
  • 8-nitrooxy-2,6-dioxabicyclo[3.3.0]octan-4-ol
Chemical and physical data
FormulaC6H9NO6
Molar mass191.139 g·mol−1
3D model (JSmol)
  • [O-][N+](=O)O[C@H]1[C@H]2OC[C@H](O)[C@H]2OC1
  • InChI=1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1 checkY
  • Key:YWXYYJSYQOXTPL-SLPGGIOYSA-N checkY
  (verify)

Isosorbide mononitrate, sold under many brand names, is a medication used for heart-related chest pain (angina), heart failure, and esophageal spasms.[3] It can be used both to treat and to prevent heart-related chest pain; however, it is generally less preferred than beta blockers or calcium channel blockers.[3] It is taken by mouth.[3]

Common side effects include headache, low blood pressure with standing, blurry vision, and skin flushing.[3] Serious side effects may include low blood pressure especially if also exposed to PDE5 inhibitors such as sildenafil.[3] Use is not recommended in pregnancy.[4] It is believed to work by relaxing smooth muscle within blood vessels.[3]

It was patented in 1971 and approved for medical use in 1981.[5] It is available as a generic medication.[4] A month's supply in the United Kingdom costs the NHS about one pound sterling per month as of 2019.[4] In the United States the wholesale cost of this amount is about US$4.30.[6] In 2017, it was the 111th most commonly prescribed medication in the United States, with more than six million prescriptions.[7][8]

References[edit]

  1. ^ a b "Isosorbide mononitrate Use During Pregnancy". Drugs.com. 28 February 2020. Retrieved 14 April 2020.
  2. ^ "WHOCC - ATC/DDD Index". www.whocc.no. Retrieved 6 September 2020.
  3. ^ a b c d e f "Isosorbide Dinitrate/Mononitrate Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 3 March 2019.
  4. ^ a b c British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. pp. 219–220. ISBN 9780857113382.
  5. ^ Fischer, Jnos; Ganellin, C. Robin (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 454. ISBN 9783527607495.
  6. ^ "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
  7. ^ "The Top 300 of 2020". ClinCalc. Retrieved 11 April 2020.
  8. ^ "Isosorbide Mononitrate - Drug Usage Statistics". ClinCalc. Retrieved 11 April 2020.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Mr._Ibrahem/Isosorbide_mononitrate&oldid=1048553050"